Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Prostate-specific antigen (PSA) is a key marker for prostate cancer monitoring.
• Elevated PSA levels are known in benign prostatic hyperplasia, but correlation with specific prostatic abnormalities is less understood.
• Limited data exists on serum PSA levels in men undergoing prostatectomy for presumed benign conditions.

Purpose of the Study:

• To correlate preoperative serum PSA levels with histopathologic findings in men with bladder outlet obstruction.
• To investigate the diagnostic utility of PSA in differentiating various prostate pathologies.

Main Methods:

• Preoperative serum PSA levels were measured in 81 men undergoing prostatectomy for bladder outlet obstruction.
• Patients were categorized into five pathologic groups: high-grade carcinoma, low-grade carcinoma, acute/chronic inflammation, prostatic intraepithelial neoplasia (PIN), and benign hyperplasia.
• PSA levels were compared across these groups.

Main Results:

• Serum PSA levels were significantly elevated in low-grade carcinoma, high-grade carcinoma, acute inflammation, and PIN compared to benign hyperplasia.
• PSA could only differentiate high-grade cancer patients with metastatic disease among the elevated groups.
• Only one patient with simple hyperplasia had abnormal PSA levels.

Conclusions:

• Elevated PSA levels are not exclusive to prostate cancer and can be observed in benign conditions like inflammation and PIN.
• PSA's ability to distinguish between different prostate pathologies, especially in non-cancerous conditions, is limited.
• Further research is needed to refine the interpretation of PSA levels in the context of various prostate diseases.